These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 2729754)
1. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Newman LS; Kreiss K; King TE; Seay S; Campbell PA Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754 [TBL] [Abstract][Full Text] [Related]
2. Compartmentalized immune response reflects clinical severity of beryllium disease. Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739 [TBL] [Abstract][Full Text] [Related]
3. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Newman LS; Mroz MM; Balkissoon R; Maier LA Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840 [TBL] [Abstract][Full Text] [Related]
4. Early pulmonary physiologic abnormalities in beryllium disease. Pappas GP; Newman LS Am Rev Respir Dis; 1993 Sep; 148(3):661-6. PubMed ID: 8368637 [TBL] [Abstract][Full Text] [Related]
5. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Tinkle SS; Newman LS Am J Respir Crit Care Med; 1997 Dec; 156(6):1884-91. PubMed ID: 9412570 [TBL] [Abstract][Full Text] [Related]
6. Serum angiotensin converting enzyme activity in chronic beryllium disease. Newman LS; Orton R; Kreiss K Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822 [TBL] [Abstract][Full Text] [Related]
15. Sarcoidosis and chronic beryllium disease: similarities and differences. Mayer AS; Hamzeh N; Maier LA Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084 [TBL] [Abstract][Full Text] [Related]
16. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529 [TBL] [Abstract][Full Text] [Related]
17. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease. Tinkle SS; Kittle LA; Newman LS J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017 [TBL] [Abstract][Full Text] [Related]
18. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Marchand-Adam S; El Khatib A; Guillon F; Brauner MW; Lamberto C; Lepage V; Naccache JM; Valeyre D Eur Respir J; 2008 Sep; 32(3):687-93. PubMed ID: 18757698 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Inoue Y; Barker E; Daniloff E; Kohno N; Hiwada K; Newman LS Am J Respir Crit Care Med; 1997 Jul; 156(1):109-15. PubMed ID: 9230733 [TBL] [Abstract][Full Text] [Related]
20. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]